Cervical Neoplasia Clinical Trial
Official title:
A Pilot Study: Measurement of Digital Colposcopy for Fluorescence Spectroscopy of the Normal Cervix for Screening, Using a Second Generation Device
The overall objective of this study is to identify potential improvements for a noninvasive
method of diagnosing dysplasia and neoplasia in the cervix using Multi-spectral Digital
Colposcopy (MDC), a device that uses fluorescence and reflectance spectroscopy to compare
images to histopathologic mapping of the cervical epithelium.
Primary Objective:
-To measure Multi-spectral Digital Colposcopy images in vivo of the cervix both before and
after acetic acid in a screening population.This is a second generation research device with
low significant risk for which we are studying MDC.
Secondary Objectives:
1. To evaluate the effect of the fading of acetic acid in the image contrast obtained over
time to see if this fading can predict the presence of any neoplasia.
2. To evaluate mapping the cervix so that software can reconstruct the cervical epithelial
map as evaluated by a Papanicolaou Smear to compare to routine colposcopic images as
well as those from the Multi-spectral Digital Colposcopy (MDC).
A colposcopy is an exam of the vagina and cervix using a magnifying lens. A multi-spectral
digital colposcopy uses a digital camera and a special light to take pictures of the cervix
and vagina.
Before taking part in this study, you will have a complete medical history recorded. You
will have a physical exam and a pap smear. Women who are able to have children must have a
negative urine pregnancy test.
You will then have a multi-spectral digital colposcopy performed during the routine
colposcopy in the outpatient clinic. A multi-spectral digital colposcopy device will shine
light on the cervix and vagina and take several pictures. The pictures will be used by the
doctors to check the cells and structure of the tissue. After the first set of pictures,
acetic acid (vinegar) will be applied to the cervix so any lesions would show up better.
Application of acetic acid is a normal part of the colposcopy and not part of the research.
About 1-2 minutes later, more pictures will be taken.
If the acetic acid/colposcopy show abnormal cells, you will have a biopsy of the cervical
canal.
If the acetic acid /colposcopy show normal cells, no biopsy will be taken.
Once you have completed the colposcopy with or without the biopsy of the cervical canal,
your participation on this study is complete.
If either your Pap smear or biopsy of the cervical canal is abnormal, the study doctor/staff
will recommend further care or treatment.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00702208 -
Feasibility of Delphi Screener for Cervical Cytology
|
Phase 2 | |
Completed |
NCT02253719 -
Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
|
N/A | |
Completed |
NCT05211271 -
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
|
N/A | |
Not yet recruiting |
NCT02908607 -
Thermal Imaging for Evaluation of the Cervix
|
Phase 1/Phase 2 | |
Terminated |
NCT00342173 -
Costa Rican Natural History Study of HPV and Cervical Neoplasia
|
||
Completed |
NCT00435214 -
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
|
||
Completed |
NCT01086709 -
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
|
||
Completed |
NCT00766701 -
Spectroscopic Evaluation of Cervical Neoplasia
|
N/A | |
Completed |
NCT00456807 -
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
|
Phase 3 |